Back to A1 a16z Capital Management, L.L.C.

BIOA

Showing 8 of 9 quarters

Position history for A1a16z Capital Management, L.L.C.'s holdings in BioAge Labs, Inc.

Yes. a16z Capital Management holds 3,233,170 shares of BIOA (BioAge Labs), worth $22.9M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. a16z Capital Management has listed BIOA in each of its last 9 quarterly 13F filings. BIOA is 0.1% of a16z Capital Management's reported 13F portfolio.

Current Value

$22.9M

Current Shares

3.2M

Total Value Change

+$4.2M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
3.2M
0.0%
$22.9M0.1%$7.09
0
2026-Q2
Unchanged
3.2M
0.0%
$79.2M0.6%$24.51
0
2026-Q1
Unchanged
3.2M
0.0%
$56.5M4.4%$17.49
0
2025-Q4
Unchanged
3.2M
0.0%
$44.1M2.8%$13.23
0
2025-Q3
Unchanged
3.2M
0.0%
$19M1.4%$5.88
0
2025-Q2
Unchanged
3.2M
0.0%
$13.4M4.3%$4.13
0
2025-Q1
Unchanged
3.2M
0.0%
$12.2M1.7%$3.76
0
2024-Q4
Increased
3.2M
+7.3%
$18.7M2.5%$5.79
55

Other major holders of BIOA: BlackRock, Inc., Jupiter Topco LLC, RA Capital Management, L.P.

Optional analytics helps us improve. How it’s used